Pushing Back Against HCM: The Role of Cardiac Myosin Inhibitors

Chair, Milind Desai, MD, MBA, Neal K. Lakdawala, MD, and Anjali Tiku Owens, MD, discuss hypertrophic cardiomyopathy in this CME/MOC/NCPD/CPE activity titled “Pushing Back Against HCM: Can Cardiac Myosin Inhibitors Alter the Disease Progression and Management Trajectory for Patients With Hypertrophic Cardiomyopathy?.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/KST865. CME/MOC/NCPD/CPE credit will be available until November 20, 2023.